CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- EIN
- 813676773
- Phone
- 972-77-331-0156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,516
- in 1 filing
Net −$6,516. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-29 | Mor George Adi Chief Executive Officer | Purchase | −4,878 | $2.05 | $10K | 134,205 |
| 2026-05-29 | Mor George Adi Chief Executive Officer | Purchase | −4,926 | $2.08 | $10K | 139,131 |
| 2022-05-24 | Maryles Joel Michael Director | Purchase | +400 | $2.89 | $1K | 1,400 |
| 2022-05-24 | Maryles Joel Michael Director | Purchase | +33 | $2.76 | $91 | 1,433 |
| 2022-05-18 | Cohen Neil Harris Director | Purchase | +2,000 | $3.19 | $6K | 12,409 |
| 2022-03-18 | Maryles Joel Michael Director | Purchase | +500 | $4.32 | $2K | 500 |
| 2022-03-18 | Maryles Joel Michael Director | Purchase | +500 | $4.36 | $2K | 1,000 |
| 2022-03-16 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.30 | $825 | 1,750 |
| 2022-03-16 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.25 | $813 | 2,000 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $4.00 | $1K | 250 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.98 | $995 | 500 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.90 | $975 | 1,000 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $4.10 | $1K | 1,250 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $4.20 | $1K | 1,500 |
| 2022-03-14 | Pfost Dale R Chief Executive Officer | Purchase | +1,800 | $3.98 | $7K | 1,800 |
| 2022-03-14 | Pfost Dale R Chief Executive Officer | Purchase | +700 | $3.97 | $3K | 2,500 |
| 2022-03-14 | Cohen Neil Harris Director | Purchase | +2,000 | $4.20 | $8K | 6,409 |
| 2022-03-14 | Cohen Neil Harris Director | Purchase | +2,000 | $4.30 | $9K | 8,409 |
| 2022-03-14 | Cohen Neil Harris Director | Purchase | +2,000 | $4.56 | $9K | 10,409 |
| 2022-03-11 | Darvish Nissim Director | Purchase | +1,200 | $4.28 | $5K | 1,200 |
Page 1 of 2 · 23 trades